← Eichor
Study identifier: NCT06668142 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

Condition: Benign Prostatic Hyperplasia  ·  Sponsor: Andromeda Surgical

PhaseNA
Planned participants54
Who can joinMale, 45 Years to no upper limit
Healthy volunteersNo

About this study

Robotic assisted surgery for benign prostatic hyperplasia (BPH)

This description comes directly from the study's public registry record.

Talk to the study team

Rami Abukhalil, MD. MPH  ·  513-808-2097  ·  rami@andromedasurgical.com

Michael Nketiah

Always discuss trial participation with your own doctor first.

Locations (3)

Universidad Catolica de ChileSantiago, Santiago Metropolitan, ChileRecruiting
Hospital Clínico de la Universidad de ChileSantiago, Santiago Metropolitan, ChileRecruiting
Tauranga Urology Research LimitedTauranga, New ZealandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06668142